It's NOT an update on 8400. It's a clinical update on WM trials. "During the conference call, Idera management will discuss the company's recent progress and provide a clinical update from the ongoing Phase 1/2 trial of IMO-8400 in Waldenstrom's Macroglobulinemia."
Read it again: "RECENT progress", "ONGOING Phase 1/2 trial of IMO-8400 in Waldenstrom's Macroglobulinemia".
To me, that means decent-to-excellent news and progress. Otherwise, they would've not added such language.
I would. This is the lowest in their history, starting right now